Absci Corp ABSI
$7.78
▲ +1.83%
(+$0.14)
⬆️ Above Yest. High
🔥 High Short Interest
🎢 High Beta
🗓️ Earnings Next Week
Open
$7.81
Prev Close
$7.64
Day Range
$7.44 – $8.14
52W Range
$2.24 – $12.06
Market Cap
$1.32B
Beta
2.41
EPS (TTM)
$-0.83
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-22 |
| Shares Out. | 168,850,000 |
| Website | absci.com/ ↗ |
| Phone | 13026587581 |
| Employees | 140 |
| Revenue | $215,000 |
| Gross Profit | $215,000 |
| Net Income | -$29.6M |
| Free Cash Flow | -$98.5M |
| Total Assets | $195.6M |
| Total Liabilities | $23.6M |
| Equity | $172.0M |
About Absci Corp
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Absci Corp is a publicly traded company under the ticker symbol ABSI on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
17 analysts (2026-07-01)